BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alarcón MA, Olivares W, Córdova-Delgado M, Muñoz-Medel M, de Mayo T, Carrasco-Aviño G, Wichmann I, Landeros N, Amigo J, Norero E, Villarroel-Espíndola F, Riquelme A, Garrido M, Owen GI, Corvalán AH. The Reprimo-Like Gene Is an Epigenetic-Mediated Tumor Suppressor and a Candidate Biomarker for the Non-Invasive Detection of Gastric Cancer. Int J Mol Sci 2020;21:E9472. [PMID: 33322837 DOI: 10.3390/ijms21249472] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Tang SY, Zhou PJ, Meng Y, Zeng FR, Deng GT. Gastric cancer: An epigenetic view. World J Gastrointest Oncol 2022; 14(1): 90-109 [DOI: 10.4251/wjgo.v14.i1.90] [Reference Citation Analysis]
2 Zeng Y, Rong H, Xu J, Cao R, Li S, Gao Y, Cheng B, Zhou T. DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer. Front Genet 2022;13:823905. [DOI: 10.3389/fgene.2022.823905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Herrera-Pariente C, Montori S, Llach J, Bofill A, Albeniz E, Moreira L. Biomarkers for Gastric Cancer Screening and Early Diagnosis. Biomedicines 2021;9:1448. [PMID: 34680565 DOI: 10.3390/biomedicines9101448] [Reference Citation Analysis]
4 Niclauss N, Gütgemann I, Dohmen J, Kalff JC, Lingohr P. Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives. Cancers (Basel) 2021;13:5660. [PMID: 34830815 DOI: 10.3390/cancers13225660] [Reference Citation Analysis]